Kavita sarin biography template

• Internship: Santa Clara Valley Medical Center Dept of Medicine () CA
• Residency: Stanford University Dept of Dermatology () CA
• Board Certification: American Board of Dermatology, Dermatology ()
• • Medical Education: Stanford University Medical Center () CA
  • PhD, Stanford University- Dept of Genetics, CA ()
  • BS, Stanford University- Computer Science, CA ()

View More Education & Certifications

• Damon Runyon Clinical Investigator Award, Damon Runyon ()
• Department of Dermatology Letter of Teaching Distinction, Stanford University ()
• F32 NRSA Ruth L.

  Kirschstein National Research Service Award, National Institutes of Health ()

• • Franklin G. Ebaugh, Jr. Award for Excellence in Advising Medical Students, Stanford University School of Medicine ()
  • K23 NCI Career Development Award, National Institutes of Health ()
  • Medical Dermatology Career Development Award, Dermatology Foundation ()
  • Medical Scientist Training Program Scholarship, National Institutes of Health ()
  • President's Scholar, Stanford University ()
  • Translational Research and Medicine Award, Stanford University ()
  • Unsung Hero Award, NBC ()

View More Honors & Awards

• Member, Stanford Center for Population Health Sciences ( - Present)
• Member, Stanford Cancer Institute ( - Present)
• Member, American Society for Human Genetics ( - Present)
• • Member, Children's Health Research Institute ( - Present)
  • Fellow, American Academy of Dermatology ( - Present)
  • Member, Society of Investigative Dermatology ( - Present)

View More Memberships

• Conditional telomerase induction causes proliferation of hair follicle stem cells
  Sarin, K.

  Y., Cheung, P., Gilison, D., Lee, E., Tennen, R. I., Wang, E., … Artandi, S. E. (). Conditional telomerase induction causes proliferation of hair follicle stem cells. NATURE, (), –

• Aging, graying and loss of melanocyte stem cells
  Sarin, K. Y., & Artandi, S. E. (). Aging, graying and loss of melanocyte stem cells.

  STEM CELL REVIEWS, 3(3), –

• TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program
  Choi, J., Southworth, L. K., Sarin, K. Y., Venteicher, A. S., Ma, W., Chang, W., … Artandi, S. E. (). TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program.

  PLOS GENETICS, 4(1).

• • Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling.
    Shkreli, M., Sarin, K. Y., Pech, M. F., Papeta, N., Chang, W., Brockman, S. A., … Artandi, S. E. (). Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling.

    Nature Medicine, 18(1), –

  • Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab
    Sarin, K. Y., & Fiorentino, D. (). Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab. ARCHIVES OF DERMATOLOGY, (9), –
  • Mosaic Activating RAS Mutations in Nevus Sebaceus and Nevus Sebaceus Syndrome
    Sun, B.

    K., Saggini, A., Sarin, K. Y., Kim, J., Benjamin, L., LeBoit, P. E., & Khavari, P. A. (). Mosaic Activating RAS Mutations in Nevus Sebaceus and Nevus Sebaceus Syndrome. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (3), –

  • Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
    Sarin, K.

    Y., Sun, B. K., Bangs, C. D., Cherry, A., Swetter, S. M., Kim, J., & Khavari, P. A. (). Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatology , (9), –

  • Dermatomyositis associated with capecitabine in the setting of malignancy.
    Chen, F. W., Zhou, X., Egbert, B.

    M., Swetter, S. M., & Sarin, K. Y. (). Dermatomyositis associated with capecitabine in the setting of malignancy. Journal of the American Academy of Dermatology, 70(2), e47–8.

  • Activating HRAS Mutation in Nevus Spilus.
    Sarin, K. Y., McNiff, J. M., Kwok, S., Kim, J., & Khavari, P. A. ().

    Activating HRAS Mutation in Nevus Spilus. Journal of Investigative Dermatology, (6), –

  • Dermatomyositis associated with capecitabine in the setting of malignancy
    Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (). Dermatomyositis associated with capecitabine in the setting of malignancy.

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(2), E47–E

  • Smoothened variants explain the majority of drug resistance in Basal cell carcinoma.
    Atwood, S. X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., Rezaee, M., … Tang, J. Y. (). Smoothened variants explain the majority of drug resistance in Basal cell carcinoma.

    Cancer Cell, 27(3), –

  • Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma.
    Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., … de Sauvage, F. J. (). Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma.

    Cancer Cell, 27(3), –

  • Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma.
    Atwood, S. X., Sarin, K. Y., Li, J. R., Yao, C. Y., Urman, N. M., Chang, A. L. S., … Oro, A. E. (). Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma.

    Journal of Investigative Dermatology, (8), –

  • Dermatologic applications of direct-to-consumer genomic analysis.
    Fogel, A. L., Azizi, N., Tang, J., & Sarin, K. Y. (). Dermatologic applications of direct-to-consumer genomic analysis. Journal of the American Academy of Dermatology, 71(5), –
  • A subdermal source: contact dermatitis.
    Fogel, A.

    L., Longmire, M., Rieger, K. E., & Sarin, K. Y. (). A subdermal source: contact dermatitis. American Journal of Medicine, (6), –

  • Molecular Profiling to Diagnose a Case of Atypical Dermatomyocitis
    Sarin, K., Chung, L., Kim, J., Higgs, B. W., Jallal, B., Yao, Y., & Fiorentino, D. ().

    Molecular Profiling to Diagnose a Case of Atypical Dermatomyocitis. Journal of Investigative Dermatology, (12).

  • Squamous Change in Basal-Cell Carcinoma with Drug Resistance.
    Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (). Squamous Change in Basal-Cell Carcinoma with Drug Resistance.

    New England Journal of Medicine, (11), –

  • Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma.
    Jaju, P. D., Nguyen, C. B., Mah, A. M., Atwood, S. X., Li, J., Zia, A., … Sarin, K. Y. (). Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma. Journal of Investigative Dermatology, (12), –
  • Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma.
    Ransohoff, K.

    J., Sarin, K. Y., & Tang, J. Y. (). Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma. Journal of Clinical Oncology , 33(24), –

  • Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
    Ally, M. S., Ransohoff, K., Sarin, K., Atwood, S.

    X., Rezaee, M., Bailey-Healy, I., … Colevas, A. D. (). Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. JAMA Dermatology, (4), –

  • Squamous Change in Basal-Cell Carcinoma with Drug Resistance
    Ransohoff, K. J., Tang, J. Y., & Sarin, K.

    Y. (). Squamous Change in Basal-Cell Carcinoma with Drug Resistance. NEW ENGLAND JOURNAL OF MEDICINE, (11), –

  • Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors
    Sarin, K. Y., Tang, J. Y., Ransohoff, K. J., & Jaju, P. D. (). Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors.

    Journal of The American Academy of Dermatology, 74(3).

  • Familial skin cancer syndromes: Increased melanoma risk
    Jaju, P. D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (). Familial skin cancer syndromes: Increased melanoma risk. Journal of The American Academy of Dermatology, 74(3).
  • Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic basal cell carcinoma
    Sarin, K.

    Y., Ally, M. S., Ransohoff, K. J., Atwood, S. X., & Rezaee, M. (). Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic basal cell carcinoma. JAMA Dermatology, 1–5.

  • An investigator-initiated open label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib
    Sarin, K.

    Y., Oro, A. E., Chang, A. L., & Danial, C. (). An investigator-initiated open label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research.

  • A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities, and controversy
    Fogel, A.

    L., & Sarin, K. Y. (). A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities, and controversy. Journal of Telemedicine and Telecare, (January).

  • The digital age of melanoma management: detection and diagnostics
    Fogel, A. L., & Sarin, K. Y. (). The digital age of melanoma management: detection and diagnostics.

    Future Medicine, 2(4), –

  • Familial skin cancer syndromes Increased melanoma risk
    Ransohoff, K. J., Jaju, P. D., Tang, J. Y., Carbone, M., Leachman, S., & Sarin, K. Y. (). Familial skin cancer syndromes Increased melanoma risk. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(3), –
  • Familial skin cancer syndromes Increased risk of nonmelanotic skin cancers and extracutaneous tumors
    Jaju, P.

    D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (). Familial skin cancer syndromes Increased risk of nonmelanotic skin cancers and extracutaneous tumors. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(3), –

  • An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
    Danial, C., Sarin, K.

    Y., Oro, A. E., & Chang, A. L. S. (). An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib. CLINICAL CANCER RESEARCH, 22(6), –

  • Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Searching.
    Ransohoff, J.

    D., Li, S., & Sarin, K. Y. (). Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Searching. JAMA Dermatology, (10), –

  • Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.
    Chahal, H. S., Wu, W., Ransohoff, K. J., Yang, L., Hedlin, H., Desai, M., … Sarin, K.

    Y. (). Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma. Nature Communications, 7, ?

  • Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets.
    Cho, H. G., Fiorentino, D., Lewis, M., Sirota, M., & Sarin, K.

    Y. (). Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets. Journal of Investigative Dermatology, (7), –

  • Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma.
    Chahal, H.

    S., Lin, Y., Ransohoff, K. J., Hinds, D. A., Wu, W., Dai, H.-ji, … Sarin, K. Y. (). Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma. Nature Communications, 7, ?

  • Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling
    Shkreli, M., Sarin, K.

    Y., Pech, M. F., Papeta, N., Chang, W., Brockman, S. A., … Artandi, S. E. (). Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. NATURE MEDICINE, 18(1), –

  • Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma.
    Jaju, P., Novoa, R.

    A., Swetter, S. M., & Sarin, K. Y. (). Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. Pediatric Dermatology.

  • Direct-to-consumer teledermatology services for pediatric patients: Room for improvement.
    Fogel, A. L., Teng, J., & Sarin, K. Y. (). Direct-to-consumer teledermatology services for pediatric patients: Room for improvement.

    Journal of the American Academy of Dermatology, 75(5), –

  • Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions
    Urman, N. M., Mirza, A., Atwood, S. X., Whitson, R. J., Sarin, K. Y., Tang, J. Y., & Oro, A. E. (). Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.

    PLOS ONE, 11(12).

  • Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk.
    Fogel, A. L., Jaju, P. D., Li, S., Halpern-Felsher, B., Tang, J. Y., & Sarin, K. Y. (). Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk.

    Journal of the American Academy of Dermatology.

  • Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age.
    Chahal, H. S., Rieger, K. E., & Sarin, K. Y. (). Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. Journal of the American Academy of Dermatology, 76(2), –
  • Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.
    Lin, Y., Chahal, H.

    S., Wu, W., Cho, H. G., Ransohoff, K. J., Dai, H., … Han, J. (). Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma. International Journal of Cancer.

  • A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities and controversy.
    Fogel, A.

    L., & Sarin, K. Y. (). A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities and controversy. Journal of Telemedicine and Telecare, 23(1), 19–

  • Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.
    Ransohoff, K.

    J., Wu, W., Cho, H. G., Chahal, H. C., Lin, Y., Dai, H.-ji, … Sarin, K. Y. (). Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. Oncotarget.

  • Basosquamous Carcinoma: Controversy, Advances, and Future Directions.
    Tan, C. Z., Rieger, K. E., & Sarin, K.

    Y. ().

  • Settings
  • Kavita Yang Sarin, 45 - Redwood City, CA - Reputation ...
  • Carousel
  • Item 3 of 4

  Basosquamous Carcinoma: Controversy, Advances, and Future Directions. Dermatologic Surgery , 43(1), 23–

  • Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma
    Jaju, P., Novoa, R. A., Swetter, S. M., & Sarin, K. Y. (). Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. PEDIATRIC DERMATOLOGY, 34(1), E35–E
  • Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma.
    Lin, Y., Chahal, H.

    S., Wu, W., Cho, H. G., Ransohoff, K. J., Song, F., … Han, J. (). Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma. International Journal of Cancer.

  • Genetic diseases associated with an increased risk of skin cancer development in childhood.
    Fogel, A.

    L., Sarin, K. Y., & Teng, J. M. C. (). Genetic diseases associated with an increased risk of skin cancer development in childhood. Current Opinion in Pediatrics.

  • Postzygotic Mutations in Beta-Actin are Associated with Becker's Nevus and Becker's Nevus Syndrome.
    Cai, E. D., Sun, B. K., Chiang, A., Rogers, A., Bernet, L., Cheng, B., … Sarin, K.

    Y. (). Postzygotic Mutations in Beta-Actin are Associated with Becker's Nevus and Becker's Nevus Syndrome. Journal of Investigative Dermatology.

  • Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution.
    Kuo, K.

    Y., Batra, P., Cho, H. G., Li, S., Chahal, H. S., Rieger, K. E., … Sarin, K. Y. (). Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution.

    Kavita sarin biography template Sarin provided a very knowledgeable diagnosis; thorough guidance. Chahal, Yuan Lin, et al. Sarin provided me with excellent care. Cases were selected according to pre-defined clinical outcome measures.

    Journal of the American Academy of Dermatology.

  • IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.
    Nirschl, C. J., Suárez-Fariñas, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., … Anandasabapathy, N. (). IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.

    Cell, (1), –e

  • Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.
    Mirza, A. N., Fry, M. A., Urman, N. M., Atwood, S. X., Roffey, J., Ott, G. R., … Oro, A. E. (). Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.

    JCI Insight, 2(21).

  • Genomic Stability in Syndromic Basal Cell Carcinoma.
    Chiang, A., Jaju, P. D., Batra, P., Rezaee, M., Epstein, E. H., Tang, J. Y., & Sarin, K. Y. (). Genomic Stability in Syndromic Basal Cell Carcinoma. The Journal of Investigative Dermatology.
  • Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.
    Whitson, R.

    J., Lee, A., Urman, N. M., Mirza, A., Yao, C. Y., Brown, A. S., … Oro, A. E. (). Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nature Medicine, 24(3), –

  • Activity of Type I and Type II Interferons in Dermatomyositis Skin Is Correlated with Characteristic Pathologic Features
    Leatham, H.

    W., Rieger, K., Chung, L., Li, S., Higgs, B. W., Yao, Y., … Fiorentino, D. (). Activity of Type I and Type II Interferons in Dermatomyositis Skin Is Correlated with Characteristic Pathologic Features. ARTHRITIS & RHEUMATOLOGY, 67.

  • Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning.
    Ransohoff, J.

    D., Nikfarjam, A., Jones, E., Loew, B., Kwong, B. Y., Sarin, K. Y., & Shah, N. H. (). Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning. JAMA Oncology, 4(4), –

  • Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort.
    Cho, H.

    G., Ransohoff, K. J., Yang, L., Hedlin, H., Assimes, T., Han, J., … Sarin, K. Y. (). Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort. Journal of the American Academy of Dermatology.

  • Azathioprine and risk of multiple keratinocyte cancers.
    Cho, H.

    G., Kuo, K. Y., Xiao, K., Batra, P., Li, S., Tang, J. Y., & Sarin, K. Y. (). Azathioprine and risk of multiple keratinocyte cancers. Journal of the American Academy of Dermatology, 78(1), 27–e1.

  • TGF-beta, Fibronectin and Integrin alpha5beta1 Promote Invasion in Basal Cell Carcinoma.
    Kuonen, F., Surbeck, I., Sarin, K.

    Y., Dontenwill, M., Ruegg, C., Gilliet, M., … Gaide, O. (). TGF-beta, Fibronectin and Integrin alpha5beta1 Promote Invasion in Basal Cell Carcinoma. The Journal of Investigative Dermatology.

  • Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes
    Ko, J.

    S., Matharoo-Ball, B., Billings, S. D., Thomson, B. J., Tang, J. Y., Sarin, K. Y., … Clarke, L. E. (). Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 26(7), –

  • Identification of Atorvastatin for Moderate to Severe Hidradenitis through Drug Repositioning Using Public Gene Expression Datasets
    Kuo, K.

    Y., Cho, H. G., & Sarin, K. Y. (). Identification of Atorvastatin for Moderate to Severe Hidradenitis through Drug Repositioning Using Public Gene Expression Datasets.

  • Biography template for professionals
  • Kavita sarin biography template free
  • Biography template microsoft word

  JOURNAL OF INVESTIGATIVE DERMATOLOGY, (5), –

  • Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility
    Cho, H. G., Kuo, K. Y., Li, S., Bailey, I., Aasi, S., Chang, A. L. S., … Sarin, K. Y. (). Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility.

    JCI INSIGHT, 3(15).

  • Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study.
    Chang, A. L., Tran, D. C., Cannon, J. G., Li, S., Jeng, M., Patel, R., … Colevas, A. D. (). Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study.

    Journal of the American Academy of Dermatology.

  • Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk
    Wu, W., Amos, C. I., Lee, J. E., Wei, Q., Sarin, K. Y., & Han, J. (). Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (9), –
  • Automated Classification of Skin Lesions: From Pixels to Practice.
    Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, J.

    (). Automated Classification of Skin Lesions: From Pixels to Practice. The Journal of Investigative Dermatology, (10), –

  • Association of multiple primary melanomas with malignancy risk: a population-based analysis of the Surveillance, Epidemiology, and End Results Program database from
    Cai, E.

    D., Swetter, S. M., & Sarin, K. Y. (). Association of multiple primary melanomas with malignancy risk: a population-based analysis of the Surveillance, Epidemiology, and End Results Program database from Journal of the American Academy of Dermatology.

  • A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
    Pastorino, S., Yoshikawa, Y., Pass, H.

    I., Emi, M., Nasu, M., Pagano, I., … Carbone, M. (). A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO

  • Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.
    Sargen, M.

    R., Cloutier, J. M., Sarin, K. Y., Rieger, K. E., Chu, P., Swetter, S. M., & Novoa, R. A. (). Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma. Pigment Cell & Melanoma Research.

  • Loss of primary cilia drives switching from Hedgehog to Ras/MAPK pathway in resistant basal cell carcinoma.
    Kuonen, F., Huskey, N.

    E., Shankar, G., Jaju, P., Whitson, R. J., Rieger, K. E., … Oro, A. E. (). Loss of primary cilia drives switching from Hedgehog to Ras/MAPK pathway in resistant basal cell carcinoma. The Journal of Investigative Dermatology.

  • Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes
    Ko, J., Matharoo-Ball, B., Billings, S., Thomson, B., Tang, J., Sarin, K., … Clarke, L.

    (). Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes. MODERN PATHOLOGY. NATURE PUBLISHING GROUP.

  • Dermatologic applications of direct-to-consumer genomic analysis
    Fogel, A., Tang, J., Sarin, K., & Azizi, N.

    (). Dermatologic applications of direct-to-consumer genomic analysis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(5), AB

  • Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations.
    Kim, T., Tafoya, E., Chelliah, M. P., Lekwuttikarn, R., Li, J., Sarin, K.

    Y., & Teng, J. (). Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations. PloS One, 14(4), e

  • The digital age of melanoma management: detection and diagnostics.
    Fogel, A. L., & Sarin, K. (). The digital age of melanoma management: detection and diagnostics.

    Melanoma Management, 2(4), –

  • Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations
    Kim, T., Tafoya, E., Chelliah, M. P., Lekwuttikarn, R., Li, J., Sarin, K. Y., & Teng, J. (). Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals with lymphatic malformations.

    PLOS ONE, 14(4).

  • Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.
    Jia, J. L., Polin, D. J., & Sarin, K. Y. (). Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.

    Seminars in Cutaneous Medicine and Surgery, 38(1), E57–E

  • Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma
    Sargen, M. R., Cloutier, J. M., Sarin, K. Y., Rieger, K. E., Chu, P., Swetter, S. M., & Novoa, R. A. (). Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.

    PIGMENT CELL & MELANOMA RESEARCH, 32(3), –

  • Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
    Chang, A. L. S., Tran, D. C., Cannon, J. G. D., Li, S., Jeng, M., Patel, R., … Colevas, A. D. (). Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 80(2), –

  • Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection.
    Nikfarjam, A., Ransohoff, J. D., Callahan, A., Jones, E., Loew, B., Kwong, B. Y., … Shah, N. H. (). Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection.

    JMIR Public Health and Surveillance, 5(2), e

  • Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort
    Cho, H. G., Ransohoff, K. J., Yang, L., Hedlin, H., Assimes, T., Han, J., … Sarin, K. Y. ().

    Biography template for professionals: Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during Such incredible, high quality dermatologist! Our results from functional characterization of these mutations shed light on SUFU's role in Hedgehog signaling, tumor progression, and highlight a way in which BCCs can arise. Here we use multidimensional genomics analysis of human and mouse drug-resistant BCCs to identify a noncanonical hedgehog activation pathway driven by the transcription factor serum response factor SRF.

    Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 79(1), +.

  • Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma
    Chiang, A., Tan, C. Z., Kuonen, F., Hodgkinson, L. M., Chiang, F., Cho, R.

    J., … Sarin, K. Y. (). Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma. Journal of INVESTIGATIVE DERMATOLOGY | Original Article | Carcinogenesis/Tumorigenesis, (11).

  • Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma
    Kuonen, F., Huskey, N.

    E., Shankar, G., Jaju, P., Whitson, R. J., Rieger, K. E., … Oro, A. E. (). Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (7), –

  • Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.
    Sohn, G.

    K., Kwon, G. P., Bailey-Healy, I., Mirza, A., Sarin, K., Oro, A., & Tang, J. Y. (). Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial. JAMA Dermatology.

  • Response to Clarifying the Current Understanding of Syndromic Basal Cell Carcinomas.
    Chiang, A., Batra, P., & Sarin, K.

    Y. (). Response to Clarifying the Current Understanding of Syndromic Basal Cell Carcinomas. The Journal of Investigative Dermatology.

  • Clonal replacement of tumor-specific T cells following PD-1 blockade.
    Yost, K. E., Satpathy, A. T., Wells, D. K., Qi, Y., Wang, C., Kageyama, R., … Chang, H. Y. (). Clonal replacement of tumor-specific T cells following PD-1 blockade.

    Nature Medicine.

  • Azathioprine and risk of multiple keratinocyte cancers
    Cho, H. G., Kuo, K. Y., Xiao, K., Batra, P., Li, S., Tang, J. Y., & Sarin, K. Y. (). Azathioprine and risk of multiple keratinocyte cancers. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 78(1), +.
  • Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in a Partial Response Despite Continuous Vismodegib Treatment
    Nayyar, P.

    M., Chang, A. L. S., Sarin, K., & Ratner, D. (). Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in a Partial Response Despite Continuous Vismodegib Treatment. DERMATOLOGIC SURGERY, 45(4), –

  • Hyperhidrosis affects quality of life in hidradenitis suppurativa: a prospective analysis.
    Hua, V.

    J., Kuo, K. Y., Cho, H. G., & Sarin, K. Y. (). Hyperhidrosis affects quality of life in hidradenitis suppurativa: a prospective analysis. Journal of the American Academy of Dermatology.

  • Assessment of readability and content of patient-initiated google search results for epidermolysis bullosa.
    Jia, J. L., Nguyen, B., & Sarin, K.

    Y. (). Assessment of readability and content of patient-initiated google search results for epidermolysis bullosa. Pediatric Dermatology.

  • A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for advanced basal cell carcinomas
    Chang, A., Duy Tran, Cannon, J., Li, S., Jeng, M., Rieger, K., … Colevas, D.

    (). A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for advanced basal cell carcinomas. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 81(4), AB8.

  • Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care
    Jia, J.

    L., Polin, D. J., & Sarin, K. Y. (). Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 38(1), E57–E

  • Comparing Online Engagement and Academic Impact of Dermatology Research: An Altmetric Attention Score and PlumX Metrics Analysis.
    Jia, J.

    L., Nguyen, B., Mills, D. E., Polin, D. J., & Sarin, K. Y. (). Comparing Online Engagement and Academic Impact of Dermatology Research: An Altmetric Attention Score and PlumX Metrics Analysis. Journal of the American Academy of Dermatology.

  • From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
    Eichstadt, S., Tang, J.

    Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Y. (). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 12, –

  • From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB).
    Eichstadt, S., Tang, J.

    Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Y. (). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). Clinical, Cosmetic and Investigational Dermatology, 12, –

  • Angular compounding for speckle reduction in optical coherence tomography using geometric image registration algorithm and digital focusing.
    Zhao, J., Winetraub, Y., Yuan, E., Chan, W.

    H., Aasi, S. Z., Sarin, K. Y., … de la Zerda, A. (). Angular compounding for speckle reduction in optical coherence tomography using geometric image registration algorithm and digital focusing. Scientific Reports, 10(1),

  • Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma.
    Sarin, K.

    Y., Lin, Y., Daneshjou, R., Ziyatdinov, A., Thorleifsson, G., Rubin, A., … Han, J. (). Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma. Nature Communications, 11(1),

  • Ways to Improve Care for LGBT Patients in Dermatology Clinics.
    Jia, J. L., Polin, D. J., & Sarin, K.

    Y. (). Ways to Improve Care for LGBT Patients in Dermatology Clinics. Dermatologic Clinics, 38(2), –

  • Sexual and Gender Minority Curricula Within US Dermatology Residency Programs.
    Jia, J. L., Nord, K. M., Sarin, K. Y., Linos, E., & Bailey, E. E. (). Sexual and Gender Minority Curricula Within US Dermatology Residency Programs.

    JAMA Dermatology.

  • Gamification improves melanoma visual identification among high school students: Results from a randomized study.
    Jia, J. L., Shen, A., Tabata, M. M., & Sarin, K. Y. (). Gamification improves melanoma visual identification among high school students: Results from a randomized study.

    Pediatric Dermatology.

  • Fitzpatrick Phototype Disparities in Identification of Cutaneous Malignancies by Google Reverse Image.
    Jia, J. L., Wang, J. Y., Mills, D. E., Shen, A., & Sarin, K. Y. (). Fitzpatrick Phototype Disparities in Identification of Cutaneous Malignancies by Google Reverse Image. Journal of the American Academy of Dermatology.

  • Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes
    Kim, J., Ko, J., Matharoo-Ball, B., Billings, S., Thomson, B., Sarin, K., … Clarke, L. (). Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes.

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER.

  • Prevalence and risk factors for high frequency basal cell carcinoma in the United States.
    Chiang, A., Solis, D. C., Rogers, H., Sohn, G. K., Cho, H. G., Saldanha, G., … Tang, J. Y. (). Prevalence and risk factors for high frequency basal cell carcinoma in the United States.

    Journal of the American Academy of Dermatology.

  • A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO, in dermatomyositis.
    Kim, Y. J., Schiopu, E., Dankó, K., Mozaffar, T., Chunduru, S., Lees, K., … Sarin, K. Y. (). A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO, in dermatomyositis.

    Journal of the American Academy of Dermatology.

  • Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry.
    Tabata, M. M., Li, S., Knight, P., Bakker, A., & Sarin, K. Y. (). Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. JCI Insight, 5(16).

  • AP-1 and TGFSS cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma.
    Yao, C. D., Haensel, D., Gaddam, S., Patel, T., Atwood, S. X., Sarin, K. Y., … Oro, A. E. (). AP-1 and TGFSS cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma.

    Nature Communications, 11(1),

  • Patient Crowdfunding for the Treatment of Cutaneous Malignancies.
    Jia, J. L., Mills, D. E., Urman, N. M., & Sarin, K. Y. (). Patient Crowdfunding for the Treatment of Cutaneous Malignancies. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.].

  • Crowdfunding for the treatment of cutaneous malignancies: Trends, correlates, and money raised
    Jia, J. L., Mills, D., & Sarin, K. Y. (). Crowdfunding for the treatment of cutaneous malignancies: Trends, correlates, and money raised. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 83(6), AB
  • Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Results from a Prospective U.S.

    Cohort Study.
    Hu, X., Kilgour, J. M., Fogel, A. L., Jia, J. L., Jaju, P. D., Tang, J. Y., & Sarin, K. Y. (). Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Results from a Prospective U.S. Cohort Study. Journal of the American Academy of Dermatology.

  • Loss-of-Function Variants in the Tumor Suppressor Gene PTPN14 confer increased Cancer Risk.
    Olafsdottir, T., Stacey, S. N., Sveinbjornsson, G., Thorleifsson, G., Norland, K., Sigurgeirsson, B., … Stefansson, K. (). Loss-of-Function Variants in the Tumor Suppressor Gene PTPN14 confer increased Cancer Risk. Cancer Research.
  • Journal attitudes and outcomes of preprints in dermatology.
    Jia, J.

    L., Hua, V. J., Mills, D. E., & Sarin, K. Y. (). Journal attitudes and outcomes of preprints in dermatology. The British Journal of Dermatology.

  • Automated detection of skin reactions in epicutaneous patch testing using machine learning.
    Chan, W. H., Srivastava, R., Damaraju, N., Do, H., Burnett, G., MacFarlane, J., … Sarin, K.

    Y. (). Automated detection of skin reactions in epicutaneous patch testing using machine learning. The British Journal of Dermatology.

  • Modulation of the Hedgehog signaling pathway in models of basal cell carcinoma by ATP-competitive PKCi inhibitors
    Roffey, J., Dillon, C., Oro, A. E., Mirza, A.

    N., Sarin, K. Y., Aasi, S. Z., … Ator, M. (). Modulation of the Hedgehog signaling pathway in models of basal cell carcinoma by ATP-competitive PKCi inhibitors. MOLECULAR CANCER THERAPEUTICS. AMER ASSOC CANCER RESEARCH.

  • TGF beta, Fibronectin and Integrin alpha 5 beta 1 Promote Invasion in Basal Cell Carcinoma
    Kuonen, F., Surbeck, I., Sarin, K.

    Y., Dontenwill, M., Ruegg, C., Gilliet, M., … Gaide, O. (). TGF beta, Fibronectin and Integrin alpha 5 beta 1 Promote Invasion in Basal Cell Carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (11), –

  • A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations
    Pastorino, S., Yoshikawa, Y., Pass, H.

    I., Emi, M., Nasu, M., Pagano, I., … Carbone, M. (). A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. JOURNAL OF CLINICAL ONCOLOGY, 36(35), +.

  • Automated Classification of Skin Lesions: From Pixels to Practice
    Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, J.

    (). Automated Classification of Skin Lesions: From Pixels to Practice. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (10), –

  • Personal genomics in dermatology: Characteristics of patients who undergo genetic testing for melanoma risk
    Fogel, A., & Sarin, K. (). Personal genomics in dermatology: Characteristics of patients who undergo genetic testing for melanoma risk.

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(5), AB

  • Prevalence of Potentially Allergenic Ingredients in Products Labeled for Eczema Care.
    Schwartz, B. L., Honari, G., Chiou, A. S., Ko, J., Sarin, K. Y., & Chen, J. K. (). Prevalence of Potentially Allergenic Ingredients in Products Labeled for Eczema Care.

    Journal of the American Academy of Dermatology.

  • Dermatology Advances Into an Era of Precision Medicine.
    Wang, J. Y., & Sarin, K. Y. (). Dermatology Advances Into an Era of Precision Medicine.
    Kavita sarin biography template word Kavita Sarin, M. She has a very positive demeanor and wonderful feeling tone. Dermatomyositis associated with capecitabine in the setting of malignancy. What a great practice this is!

    JAMA Dermatology.

  • Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas into Clinical Research.
    Wallis, D., Stemmer-Rachamimov, A., Adsit, S., Korf, B., Pichard, D., Blakeley, J., & Sarin, K. Y. (). Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas into Clinical Research.

    Neurology.

  • Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma.
    Kilgour, J. M., Shah, A., Urman, N. M., Eichstadt, S., Do, H. N., Bailey, I., … Sarin, K. Y. (). Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma.

    Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

  • Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics.
    Kilgour, J. M., Jia, J. L., & Sarin, K. Y. (). Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics.

    Cancers, 13(15).

  • Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: A retrospective analysis of 2 U.S. cohorts.
    Kilgour, J. M., Li, S., & Sarin, K. Y. (). Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: A retrospective analysis of 2 U.S.

    cohorts. JAAD International, 3, 42–

  • Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex.
    Lee, G. H., Lekwuttikarn, R., Tafoya, E., Martin, M., Sarin, K. Y., & Teng, J. M. (). Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex.

    The Journal of Investigative Dermatology.

  • Characterization of comorbidity heterogeneity among 13, patients with hidradenitis suppurativa.
    Hua, V. J., Kilgour, J. M., Cho, H. G., Li, S., & Sarin, K. Y. (). Characterization of comorbidity heterogeneity among 13, patients with hidradenitis suppurativa.

    JCI Insight.

  • Treatment of Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat.
    Kilgour, J. M., Shah, A., Eichstadt, S., Bailey, I., Aasi, S. Z., & Sarin, K. Y. (). Treatment of Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat.

    JAMA Dermatology.

  • Development of a Core Outcome Set for Basal Cell Carcinoma (BCC), Including Low-Risk and Advanced Tumors.
    Schlessinger, D. I., Reynolds, K. A., Dirr, M. K. A., Ibrahim, S. A., Yanes, A. F., Lazaroff, J. M., … Alam, M. (). Development of a Core Outcome Set for Basal Cell Carcinoma (BCC), Including Low-Risk and Advanced Tumors.

    Journal of the American Academy of Dermatology.

  • Partnering with a senior living community to optimize teledermatology via full body skin screening during the COVID pandemic: a pilot program
    Trinh, P., Yekrang, K., Phung, M., Pugliese, S., Chang, A. L. S., Bailey, E. E., … Sarin, K. Y. (). Partnering with a senior living community to optimize teledermatology via full body skin screening during the COVID pandemic: a pilot program.

    Skin Health and Disease, 2(3).

  • Single-cell analysis of human basal cell carcinoma reveals novel regulators of tumor growth and the tumor microenvironment.
    Guerrero-Juarez, C. F., Lee, G. H., Liu, Y., Wang, S., Karikomi, M., Sha, Y., … Atwood, S. X. (). Single-cell analysis of human basal cell carcinoma reveals novel regulators of tumor growth and the tumor microenvironment.

    Science Advances, 8(23), eabm

  • Tuberous sclerosis and risk of skin cancer: a nationwide cohort study in the United States.
    Trinh, P., Li, S., & Sarin, K. Y. (). Tuberous sclerosis and risk of skin cancer: a nationwide cohort study in the United States. Journal of the American Academy of Dermatology.
  • ERK2 MAP kinase regulates SUFU binding by multisite phosphorylation of GLI1.
    Bardwell, A.

    J., Wu, B., Sarin, K. Y., Waterman, M. L., Atwood, S. X., & Bardwell, L. (). ERK2 MAP kinase regulates SUFU binding by multisite phosphorylation of GLI1. Life Science Alliance, 5(11).

  • Neurofibromatosis Type 1 and Risk of Skin Cancer.
    Trinh, P., Li, S., & Sarin, K. Y. (). Neurofibromatosis Type 1 and Risk of Skin Cancer.

    JAMA Dermatology.

  • Flexible method for generating needle-shaped beams and its application in optical coherence tomography
    Zhao, J., Winetraub, Y., Du, L., Vleck, A. V., Ichimura, K., Huang, C., … de la Zerda, A. (). Flexible method for generating needle-shaped beams and its application in optical coherence tomography. Optica, 9(8).

  • Sociodemographic disparities in patch testing for commercially insured dermatitis patients: a retrospective analysis of administrative claims data.
    Qian, M. F., Li, S., Honari, G., Sarin, K. Y., & Chen, J. K. (). Sociodemographic disparities in patch testing for commercially insured dermatitis patients: a retrospective analysis of administrative claims data.

    Journal of the American Academy of Dermatology.

  • Assessment of Comorbidities Associated With Allergic Contact Dermatitis in the United States: A Retrospective Claims-Based Study.
    Hua, V. J., Li, S., Qian, M. F., Honari, G., Sarin, K. Y., & Chen, J. K. (). Assessment of Comorbidities Associated With Allergic Contact Dermatitis in the United States: A Retrospective Claims-Based Study.

    Dermatitis : Contact, Atopic, Occupational, Drug.

  • LY6D marks pre-existing resistant basosquamous tumor subpopulations.
    Haensel, D., Gaddam, S., Li, N. Y., Gonzalez, F., Patel, T., Cloutier, J. M., … Oro, A. E. (). LY6D marks pre-existing resistant basosquamous tumor subpopulations. Nature Communications, 13(1),
  • Rapid Cellular-Resolution Skin Imaging with Optical Coherence Tomography Using All-Glass Multifocal Metasurfaces.
    Zhao, J., Van Vleck, A., Winetraub, Y., Du, L., Han, Y., Aasi, S., … de la Zerda, A.

    (). Rapid Cellular-Resolution Skin Imaging with Optical Coherence Tomography Using All-Glass Multifocal Metasurfaces. ACS Nano.

  • Prevalence of allergic contact dermatitis following patch testing in patients with atopic dermatitis: a retrospective United States claims-based study.
    Qian, M. F., Li, S., Honari, G., Sarin, K.

    Y., & Chen, J. K. (). Prevalence of allergic contact dermatitis following patch testing in patients with atopic dermatitis: a retrospective United States claims-based study. Journal of the American Academy of Dermatology.

  • Development of a novel MEK inhibitor, NFX, as a chemoprevention agent for squamous cell carcinoma.
    Sarin, K.

    Y., Kincaid, J., Sell, B., Shahryari, J., Duncton, M. A. J., Morefield, E., … Tsai, K. Y. (). Development of a novel MEK inhibitor, NFX, as a chemoprevention agent for squamous cell carcinoma. CANCER PREVENTION RESEARCH. AMER ASSOC CANCER RESEARCH.

  • Development of a novel MEK inhibitor, NFX, as a chemoprevention agent for squamous cell carcinoma
    Sarin, K.

    Y., Kincaid, J., Sell, B., Shahryari, J., Duncton, M. A. J., Morefield, E., … Tsai, K. Y. (). Development of a novel MEK inhibitor, NFX, as a chemoprevention agent for squamous cell carcinoma. CANCER PREVENTION RESEARCH. AMER ASSOC CANCER RESEARCH.

  • Modulation of Inflammatory Proteins in Serum May Reflect Cutaneous Immune Responses in Cancer Immunotherapy.
    Han, J., Correa da Rosa, J., Agarwal, A., Owji, S., Yassky, D., Luu, Y., … Gulati, N.

    (). Modulation of Inflammatory Proteins in Serum May Reflect Cutaneous Immune Responses in Cancer Immunotherapy. JID Innovations : Skin Science from Molecules to Population Health, 3(2),

  • Sociodemographic disparities in patch testing for commercially insured patients with dermatitis: A retrospective analysis of administrative claims data
    Qian, M.

    F., Li, S., Honari, G., Sarin, K. Y., & Chen, J. K. (). Sociodemographic disparities in patch testing for commercially insured patients with dermatitis: A retrospective analysis of administrative claims data. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 87(6), –

  • The type 1 interferon signature reflects multiple phenotypic and activity measures in dermatomyositis.
    Tabata, M.

    M., Hodgkinson, L. M., Wu, T. T., Li, S., Huard, C., Zhao, S., … Fiorentino, D. (). The type 1 interferon signature reflects multiple phenotypic and activity measures in dermatomyositis.

    Kavita sarin biography template pdf Autoantibody profiling of patient IgG samples was performed using a antigen array. I'm delighted I've found a dermatologist I am totally confident in and look forward to my next check up! A selection of 39 publications including case reports and series, retrospective studies, and systematic reviews of the literature were included. Expression-based systematic drug repositioning has been explored to predict novel treatments for a number of skin disorders.

    Arthritis & Rheumatology (Hoboken, N.J.).

  • cNF-Skindex in adults living with Neurofibromatosis 1: severity strata in France and validation in US adults.
    Fertitta, L., Sarin, K. Y., Bergqvist, C., Patel, E., Peiffer, B., Moryousef, S., … Wolkenstein, P. (). cNF-Skindex in adults living with Neurofibromatosis 1: severity strata in France and validation in US adults.

    The Journal of Investigative Dermatology.

  • Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during
    Cai, E. D., Swetter, S. M., & Sarin, K. Y. (). Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 88(5), e–e
  • RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.
    Rhodes, S.

    D., McCormick, F., Cagan, R. L., Bakker, A., Staedtke, V., Ly, I., … Sarin, K. Y. (). RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. The Journal of Investigative Dermatology.

    Biography template free Changes in the IFN1 score over time were significantly associated with changes in skin or muscle disease activity. Validation was conducted using Optum's de-identified Clinformatics Data Mart Database of national insurance claims. Furthermore, with increasing numbers of cutaneous neurofibromas, the odds ratio of malignant peripheral nerve sheath tumor increased. Identification of these high-risk patients is essential for preventive behavior reinforcement, genetic counseling, and ensuring other required cancer screenings.

  • Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.
    Cannon, A., Sarin, K. Y., Petersen, A. K., Pichard, D. C., Wolters, P. L., Erickson, G., … Plotkin, S. R. (). Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.

    Clinical Trials (London, England),

  • Hidradenitis suppurativa and Ehlers-Danlos syndrome: A case-control study.
    Hua, V. J., Li, S., Sarin, K. Y., & Aleshin, M. (). Hidradenitis suppurativa and Ehlers-Danlos syndrome: A case-control study. JAAD International, 12, 70–
  • Advances in cutaneous squamous cell carcinoma.
    Winge, M.

    C., Kellman, L. N., Guo, K., Tang, J. Y., Swetter, S. M., Aasi, S. Z., … Khavari, P. A. (). Advances in cutaneous squamous cell carcinoma. Nature Reviews. Cancer.

  • Flexible method for generating needle-shaped beams and its application in optical coherence tomography.
    Zhao, J., Winetraub, Y., DU, L., VAN Vleck, A., Ichimura, K., Huang, C., … DE LA Zerda, A.

    (). Flexible method for generating needle-shaped beams and its application in optical coherence tomography. Optica, 9(8), –

  • A Call for Discovery and Therapeutic Development for Cutaneous Neurofibromas.
    Blakeley, J. O., Le, L. Q., Lee, S. Y., Ly, I., Rhodes, S. D., Romo, C. G., … Wolkenstein, P.

    (). A Call for Discovery and Therapeutic Development for Cutaneous Neurofibromas. The Journal of Investigative Dermatology.

  • Cross-comparison of inflammatory skin disease transcriptomics identifies PTEN as a pathogenic disease classifier in cutaneous lupus erythematosus.
    Aevermann, B. D., Di Domizio, J., Olah, P., Saidoune, F., Armstrong, J.

    M., Bachelez, H., … Gilliet, M. (). Cross-comparison of inflammatory skin disease transcriptomics identifies PTEN as a pathogenic disease classifier in cutaneous lupus erythematosus. The Journal of Investigative Dermatology.

  • Development of a digital tool for home-based monitoring of skin disease for older adults.
    van Egmond, S., Cai, Z.

    R., Nava, V., Joy de Vere Hunt, I., Rapaport, B. R., Ko, J., … Linos, E. (). Development of a digital tool for home-based monitoring of skin disease for older adults. Skin Health and Disease, 3(5), e

  • Development of a MEK inhibitor, NFX, as a chemoprevention agent for squamous cell carcinoma.
    Sarin, K.

    Y., Kincaid, J., Sell, B., Shahryari, J., Duncton, M. A., Morefield, E., … Tsai, K. Y. (). Development of a MEK inhibitor, NFX, as a chemoprevention agent for squamous cell carcinoma. Science Translational Medicine, 15(), eade

  • A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
    Fertitta, L., Bergqvist, C., Sarin, K., Plotkin, S.

    R., Moertel, C., Petersen, A. J., … Wolkenstein, P. (). A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. The British Journal of Dermatology.

  • Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1.
    Romo, C.

    G., Sarin, K. Y., & Blakeley, J. O. (). Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1. The British Journal of Dermatology.

  • Impaired innate and adaptive immune responses to BNTb2 SARS-CoV-2 vaccination in systemic lupus erythematosus.
    Sarin, K. Y., Zheng, H., Chaichian, Y., Arunachalam, P.

    S., Swaminathan, G., Eschholz, A., … Zaba, L. C. (). Impaired innate and adaptive immune responses to BNTb2 SARS-CoV-2 vaccination in systemic lupus erythematosus. JCI Insight, 9(5).

  • Noninvasive virtual biopsy using micro-registered optical coherence tomography (OCT) in human subjects.
    Winetraub, Y., Van Vleck, A., Yuan, E., Terem, I., Zhao, J., Yu, C., … de la Zerda, A.

    (). Noninvasive virtual biopsy using micro-registered optical coherence tomography (OCT) in human subjects. Science Advances, 10(15), eadi

  • Filling the Prescription Gap: The Value of Community Support in Psoriasis Management.
    Leeolou, M. C., Sarin, K. Y., & Fiorentino, D. F. (). Filling the Prescription Gap: The Value of Community Support in Psoriasis Management.

    The British Journal of Dermatology.

  • Effect of NFX MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
    Sarin, K. Y., Bradshaw, M., O'Mara, C., Shahryari, J., Kincaid, J., Kempers, S., … Le, L. Q. (). Effect of NFX MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.

    Science Advances, 10(18), eadk

  • Parental E-Cigarette Use and Pediatric Atopic Dermatitis.
    Youn, G. M., Sarin, K. Y., Chiou, A. S., Chen, J. K., & Honari, G. (). Parental E-Cigarette Use and Pediatric Atopic Dermatitis. JAMA Dermatology.
  • Analysing common topics of secure patient messages in hidradenitis suppurativa: a text-embedding and natural language-processing approach.
    Chen, M.

    L., Kim, J., Naik, H. B., Aleshin, M. A., Sarin, K. Y., Barnes, L. A., & Linos, E. (). Analysing common topics of secure patient messages in hidradenitis suppurativa: a text-embedding and natural language-processing approach. The British Journal of Dermatology.

  • Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.
    Novelli, F., Yoshikawa, Y., Vitto, V.

    A., Modesti, L., Minaai, M., Pastorino, S., … Carbone, M. (). Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling. Proceedings of the National Academy of Sciences of the United States of America, (29), e

  • Unveiling the genetic landscape of hereditary melanoma: From susceptibility to surveillance.
    Zheng, C., & Sarin, K.

    Y. (). Unveiling the genetic landscape of hereditary melanoma: From susceptibility to surveillance. Cancer Treatment and Research Communications, 40,

  • Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1.
    Lin, M. J., Yao, H., Vera, K., Patel, E., Johnson, M., Caroline, P., … Sarin, K.

    Y. (). Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1. JAMA Dermatology.

  • TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis.
    Wu, Y., Deshpande, A., Geraci, N., Budde, P., Sellers, V., Velisetty, P., … Bender, A.

    T. (). TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis. Arthritis & Rheumatology (Hoboken, N.J.).

  • Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis.
    Starrett, G.

    J., Baikie, B. C., Stoff, B. K., Grossniklaus, H. E., Van Buren, I., Berry, E. G., … Sargen, M. R. (). Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, OF1–OF

  • Toll-Like Receptor 7/8 Activation of Immune and Non-Immune Cells in Muscle by RNA-Containing Immune Complexes Can Contribute to Inflammation and the Pathogenesis of Myositis
    Wu, Y., Deshpande, A., Geraci, N., Sellers, V., Velisetty, P., Fiorentino, D., … Bender, A.

    (). Toll-Like Receptor 7/8 Activation of Immune and Non-Immune Cells in Muscle by RNA-Containing Immune Complexes Can Contribute to Inflammation and the Pathogenesis of Myositis. ARTHRITIS & RHEUMATOLOGY. WILEY.

  • When savings fall short: drug coupons for generic prescriptions do not always result in savings for patients.
    Leeolou, M.

    C., Jia, J. L., Pham, D., & Sarin, K. Y. (). When savings fall short: drug coupons for generic prescriptions do not always result in savings for patients. Journal of the American Academy of Dermatology.

  • Identification of activating hotspot mutations in acrochordons through next-generation sequencing
    Jia, J.

    L., Wang, J. Y., Chan, W. H., Lanoue, J., Do, H., Rieger, K. E., … Sarin, K. Y. (). Identification of activating hotspot mutations in acrochordons through next-generation sequencing. JAAD INTERNATIONAL, 18, 17–

  • Identification of activating hotspot mutations in acrochordons through next-generation sequencing.
    Jia, J.

    L., Wang, J. Y., Chan, W. H., Lanoue, J., Do, H., Rieger, K. E., … Sarin, K. Y. (). Identification of activating hotspot mutations in acrochordons through next-generation sequencing. JAAD International, 18, 17–

  • IFI27 Is Differentially Upregulated in Anti-MDA5 Dermatomyositis and Correlates with the Presence of Interstitial Lung Disease
    Leeolou, M., Chung, L., Sarin, K., & Fiorentino, D.

    (). IFI27 Is Differentially Upregulated in Anti-MDA5 Dermatomyositis and Correlates with the Presence of Interstitial Lung Disease. ARTHRITIS & RHEUMATOLOGY. WILEY.

View More Publications

Open Trials